Akari Therapeutics Plc (AKTX)

4.161 -0.339 (-7.533%)

IEX Real-Time Price

9:38:42 AM EST.

NASDAQ Capital Market : Healthcare

Prev Close 4.5

Price Open 4.46

Volume: 222,326

Avg Volume: 3.94M

Market Cap: 65.77M

P/E Ratio -9.91

52 Wk Range 1.56-9.2



AKTX Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
13.94M
222,883
2.51
1.60%

2018-09-28
13.94M
264,889
3.20
1.90%

2018-09-14
13.94M
264,242
4.42
1.90%

2018-08-31
13.94M
275,764
9.33
1.98%




AKTX Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-11-15
Q3 2018
N/A
0.00 (0)
-0.04
0.00

2018-08-17
Q2 2018
N/A
0.00 (0)
-0.28
0.00

2018-07-02
Q1 2018
N/A
0.00 (0)
0.00
0.00

2018-05-21
Q1 2018
N/A
-1.00 (1)
0.00
0.00

News

SDRL, SBGL and CRBP among premarket gainers (2019-03-19 09:13 SeekingAlpha)

Altimmune (NASDAQ: ALT ) +44% on positive NasoVAX data . More news on: Altimmune, Inc., Vaxart, Inc., Cellectar Biosciences, Inc., Stocks on the move, Read more …

 


Statistics

Shares Outstanding: 15.81M

Top 15 Institution Percent: 13.30

Price To Sales: N/A

Price To Book: 11.46

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -143.05

Return On Equity: -259.21

Profit Margin: N/A

Price History

Beta: -3.72

50-day Moving Avg: 2.19

200-day Moving Avg: 1.99

YTD Change: 170.27

5-day Change: -23.73

1-month Change: 135.60

3-month Change: 155.68

6-month Change: 123.58

1-year Change: 106.42

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Akari Therapeutics Plc

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.akaritx.com

Akari Therapeutics PLC is a biopharmaceutical company in clinical stage. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system and the eicosanoid system.